Clinical cell therapy guidelines for neurorestoration (China version 2016)

What will your doctor take from this to get you closer to 100% recovery? You and your doctors' goal is 100% recovery? Isn't it?  If not you need your doctor to be fired.
https://www.dovepress.com/articles.php?article_id=31288

Authors Huang H, Chen L, Zou Q, Han F, Sun T, Mao G, He X
Received 25 June 2016
Accepted for publication 24 August 2016
Published 13 February 2017 Volume 2017:5 Pages 39—46
DOI https://doi.org/10.2147/JN.S115756
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Hari Shanker Sharma

Hongyun Huang,¹ Lin Chen,² Qingyan Zou,³ Fabin Han,⁴ Tiansheng Sun,⁵ Gengsheng Mao,¹ Xijing He<sup>6

1</sup>Institute of Neurorestoratology, General Hospital of Armed Police Forces, ²Department of Neurosurgery, Yuquan Hospital, Tsinghua University, Beijing, ³Guangdong 999 Brain Hospital, Guangzhou, ⁴Centre for Stem Cells and Regenerative Medicine, Affiliated Hospital of Taishan Medical University, Liaocheng, Shandong, ⁵Department of Orthopedics, Beijing Army General Hospital, Beijing, ⁶Second Department of Orthopedics, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China

On behalf of the Chinese Association of Neurorestoratology and Chinese Branch of the International Association of Neurorestoratology


Abstract: Cell therapy has been shown to be a key clinical therapeutic option for central ­nervous system disease or damage, and >30 types of cells have been identified through preclinical studies as having the capacity for neurorestoration. To standardize the clinical procedures of cell therapy as one of the strategies for treating neurological disorders, the first set of guidelines governing the clinical application of neurorestoration was completed in 2011 by the Chinese Branch of the International Association of Neurorestoratology. Given the rapidly advancing state of the field, the Neurorestoratology Professional Committee of Chinese Medical Doctor Association (Chinese Association of Neurorestoratology) and the Chinese Branch of the International Association of Neurorestoratology have approved the current version known as the “Clinical Cell Therapy Guidelines for Neurorestoration (China Version 2016)”. We hope this guideline will reflect the most recent results demonstrated in preclinical research, transnational studies, and evidence-based clinical studies, as well as guide clinical practice in applying cell therapy for neurorestoration.

Keywords: cell therapy, neurorestoration, China, clinical application

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]